Last reviewed · How we verify
standard chemotherapy medicine combined with Chinese herbs — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
standard chemotherapy medicine combined with Chinese herbs (standard chemotherapy medicine combined with Chinese herbs) — First Affiliated Hospital, Sun Yat-Sen University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| standard chemotherapy medicine combined with Chinese herbs TARGET | standard chemotherapy medicine combined with Chinese herbs | First Affiliated Hospital, Sun Yat-Sen University | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- standard chemotherapy medicine combined with Chinese herbs CI watch — RSS
- standard chemotherapy medicine combined with Chinese herbs CI watch — Atom
- standard chemotherapy medicine combined with Chinese herbs CI watch — JSON
- standard chemotherapy medicine combined with Chinese herbs alone — RSS
Cite this brief
Drug Landscape (2026). standard chemotherapy medicine combined with Chinese herbs — Competitive Intelligence Brief. https://druglandscape.com/ci/standard-chemotherapy-medicine-combined-with-chinese-herbs. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab